Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
about
Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETPredictive value of interim PET/CT in DLBCL treated with R-CHOP: meta-analysisPrognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis.Predictive Significance of a New Prognostic Score for Patients With Diffuse Large B-Cell Lymphoma in the Interim-Positron Emission Tomography Findings.Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.Primary mediastinal B-cell lymphoma - metabolic and anatomical features in 18FDG-PET/CT and response to therapy.When should FDG-PET be used in the modern management of lymphoma?Elevated tumor-to-liver uptake ratio (TLR) from (18)F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.Contrast-enhanced ultrasound in the therapeutic assessment of diffuse large B-cell lymphoma: A case report.Interim PET-CT may predict PFS and OS in T-ALL/LBL adult patients.Interim 18F-FDG PET/CT improves the prognostic value of S-IPI, R-IPI and NCCN-IPI in patients with diffuse large B-cell lymphoma.Prognostic value of pre- and post-transplantation 18F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantation.The rate of reduction in the maximum standardized uptake value from the initial to the post-R-CHOP therapy in positron emission tomography scan predicts disease progression in diffuse large B cell lymphoma patients.Metabolic tumor volume changes assessed by interval 18fluorodeoxyglucose positron emission tomography-computed tomography for the prediction of complete response and survival in patients with diffuse large B-cell lymphoma.
P2860
Q27314782-CDEC2BF5-F439-448C-8CA2-CD638B97CDF9Q27694674-F1BA7057-ADD6-4FF6-A5DB-47FEE73BA555Q35091121-7A085139-C870-41A6-B192-D13B07D7A72DQ35858346-61260CE3-3645-4AE8-9AE3-810D98C273D0Q36581182-693DB75D-1B38-4F08-8DCD-B8EA39B5F6A4Q37240835-A22D33D2-645F-4151-AFC6-8B9FBCE24875Q37274345-56087803-A939-470A-B738-2E7C4B0E9C51Q38153086-0D73F6C9-130E-43EE-BE13-13F6E08FA327Q38622719-18447B89-8D88-4E4C-8529-DD084471CA9CQ38836081-73017C66-4A7B-4FC6-BE49-E74954BD9476Q40356629-B15EE387-0136-4629-9FBF-712BAE8F5D37Q43852845-C47756F8-66DA-4A47-BDD2-1B68BA915EFBQ44197345-B3005640-966E-46BA-B83F-4FF303C7C9D4Q47788594-65F0B864-AB26-4303-9CD9-ABE667252126Q48516167-9AFD8D21-F15C-476C-AC92-9B404DF539DAQ49894028-8ED3DAE3-B21F-4DDA-930B-2FE87438CCDEQ53080386-F9349F92-7A77-4095-AD85-755F4EB5AEE9Q55660635-6503DB5F-3550-4109-B1B7-40490CB6B63A
P2860
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
@en
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
@nl
type
label
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
@en
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
@nl
prefLabel
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
@en
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma.
@nl
P2093
P2860
P1476
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
@en
P2093
Armando Lopez-Guillermo
Francesca Pons
Jordina Rovira
Silvia Fuertes
Sonia Rodríguez
Xavier Setoain
P2860
P2888
P304
P356
10.1007/S00259-012-2320-8
P577
2013-01-23T00:00:00Z